--- title: "Smith & Nephew (LON:SN) Hits New 1-Year High - Here's Why" type: "News" locale: "en" url: "https://longbridge.com/en/news/279116154.md" description: "Smith & Nephew (LON:SN) reached a new 52-week high of GBX 1,250.50, closing at GBX 1,248 with a trading volume of 1,196,793 shares. Analysts have mixed opinions, with Royal Bank of Canada downgrading the stock to \"sector perform\" and lowering the price target to GBX 1,350. Berenberg Bank and Panmure Gordon maintained \"hold\" ratings with targets of GBX 1,300 and GBX 1,200, respectively. The stock has a market cap of £13.68 billion and a consensus rating of \"Hold\" with an average price target of GBX 1,381.33." datetime: "2026-03-14T08:49:09.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/279116154.md) - [en](https://longbridge.com/en/news/279116154.md) - [zh-HK](https://longbridge.com/zh-HK/news/279116154.md) --- # Smith & Nephew (LON:SN) Hits New 1-Year High - Here's Why Smith & Nephew plc (LON:SN - Get Free Report) hit a new 52-week high on Friday . The stock traded as high as GBX 1,250.50 and last traded at GBX 1,248, with a volume of 1196793 shares trading hands. The stock had previously closed at GBX 1,240.50. Get **Smith & Nephew** alerts: ## Analyst Ratings Changes Several brokerages have recently commented on SN. Royal Bank Of Canada downgraded Smith & Nephew to a "sector perform" rating and lowered their price objective for the stock from GBX 1,700 to GBX 1,350 in a research note on Wednesday, December 17th. Berenberg Bank reaffirmed a "hold" rating and set a GBX 1,300 target price on shares of Smith & Nephew in a research report on Friday, January 23rd. Finally, Panmure Gordon reiterated a "hold" rating and set a GBX 1,200 price target on shares of Smith & Nephew in a report on Tuesday, December 9th. Two equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of GBX 1,381.33. **Read Our Latest Analysis on Smith & Nephew** ## Smith & Nephew Price Performance The firm has a market cap of £13.68 billion, a PE ratio of 44.93, a P/E/G ratio of 0.46 and a beta of 0.68. The company has a debt-to-equity ratio of 62.90, a current ratio of 2.57 and a quick ratio of 0.84. The business's fifty day moving average is GBX 1,272.11 and its 200-day moving average is GBX 1,298.93. ## About Smith & Nephew (Get Free Report) Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. ## Further Reading - Five stocks we like better than Smith & Nephew - A personal warning from Martin Weiss (Please read) - SpaceX IPO Confirmed: Claim Your Stake Today - Iran isn't the real war - This coin has everything going for it - Only 500 people today… _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in Smith & Nephew Right Now? Before you consider Smith & Nephew, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew wasn't on the list. While Smith & Nephew currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [SNN.US](https://longbridge.com/en/quote/SNN.US.md) ## Related News & Research - [Barclays Reaffirms Their Hold Rating on Smith & Nephew (SN)](https://longbridge.com/en/news/277593357.md) - [Smith & Nephew (LON:SN) Hits New 12-Month High - Here's What Happened](https://longbridge.com/en/news/275188972.md) - [Antofagasta (LON:ANTO) Given "Hold" Rating at Berenberg Bank](https://longbridge.com/en/news/282982464.md) - [Foresight VCT (LON:FTV) Releases Quarterly Earnings Results](https://longbridge.com/en/news/282722766.md) - [Jefferies Financial Group Reaffirms Buy Rating for GSK (LON:GSK)](https://longbridge.com/en/news/282708593.md)